In conclusion, both persistent serum eosinophilia and atopy are associated with more severe phenotypes of AA, but future multiomics studies should establish if EoAA may represent a distinctive clinical endotype meritful of targeted therapeutic approach (i.e., IL-5 antagonists). The gene discussed is IL5; the disease is Increased total eosinophil count.